Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage

医学 西洛他唑 阿司匹林 冲程(发动机) 脑出血 内科学 脑梗塞 心脏病学 危险系数 缺血 蛛网膜下腔出血 置信区间 机械工程 工程类
作者
Bum Joon Kim,Sun U. Kwon,Joung-Ho Park,Yong‐Jae Kim,Keun‐Sik Hong,Ka Sing Wong,Sungwook Yu,Yang‐Ha Hwang,Ji Sung Lee,Juneyoung Lee,Jong-Ho Rha,Sung Hyuk Heo,Seong Hwan Ahn,Woo‐Keun Seo,Jong‐Moo Park,Ju-Hun Lee,Jee‐Hyun Kwon,Sung‐Il Sohn,Jin‐Man Jung,Jose C. Navarro
出处
期刊:Stroke [Lippincott Williams & Wilkins]
卷期号:51 (3): 931-937 被引量:28
标识
DOI:10.1161/strokeaha.119.023855
摘要

Background and Purpose— Although cilostazol has shown less hemorrhagic events than aspirin, only marginal difference was observed in hemorrhagic stroke events among patients at high risk for cerebral hemorrhage. To identify patients who would most benefit from cilostazol, this study analyzed interactions between treatment and subgroups of the PICASSO trial (Prevention of Cardiovascular Events in Asian Ischemic Stroke Patients With High Risk of Cerebral Hemorrhage). Methods— Ischemic stroke patients with a previous intracerebral hemorrhage or multiple microbleeds were randomized to treatment with cilostazol or aspirin and followed up for a mean 1.8 years. Efficacy, defined as the composite of any stroke, myocardial infarction, and vascular death, and safety, defined as the incidence of hemorrhagic stroke, were analyzed in the 2 groups. Interactions between treatment and age, sex, presence of hypertension and diabetes mellitus, index of high-risk cerebral hemorrhage, and white matter lesion burden were analyzed for primary and key secondary outcomes. Changes in vital signs and laboratory results were compared in the 2 groups. Results— Among all 1534 patients enrolled, a significant interaction between treatment group and index of high risk for cerebral hemorrhage on hemorrhagic stroke ( P for interaction, 0.03) was observed. Hemorrhagic stroke was less frequent in the cilostazol than in the aspirin group in patients with multiple microbleeds (1 versus 13 events; hazard ratio, 0.08 [95% CI, 0.01–0.61]; P =0.01). A marginal interaction between treatment group and white matter change on any stroke ( P for interaction, 0.08) was observed. Cilostazol reduced any stroke significantly in patients with mild (5 versus 16 events; hazard ratio, 0.36 [95% CI, 0.13–0.97]; P =0.04)-to-moderate (16 versus 32 events; hazard ratio, 0.50 [95% CI, 0.29–0.92]; P =0.03) white matter changes. Heart rate and HDL (high-density lipoprotein) cholesterol level were significantly higher in the cilostazol group than in the aspirin group at follow-up. Conclusions— Cilostazol may be more beneficial for ischemic stroke patients with multiple cerebral microbleeds and before white matter changes are extensive. Registration— URL: https://www.clinicaltrials.gov . Unique identifier: NCT01013532.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
魏大勋完成签到,获得积分10
刚刚
小鱼爱吃鱼完成签到 ,获得积分10
刚刚
1秒前
1秒前
respect完成签到,获得积分10
2秒前
fantasy的应助被溯_采纳,获得10
2秒前
qianqina发布了新的文献求助10
2秒前
Albert完成签到,获得积分10
5秒前
海阔天空发布了新的文献求助10
5秒前
夜枭发布了新的文献求助10
5秒前
Luka完成签到,获得积分10
6秒前
15735802374完成签到 ,获得积分10
6秒前
搜集达人的应助被根狗采纳,获得10
6秒前
7秒前
7秒前
each完成签到,获得积分10
7秒前
健忘怜雪完成签到,获得积分10
7秒前
风吹麦浪发布了新的文献求助10
8秒前
鲸鱼完成签到,获得积分10
8秒前
wei_ahpu完成签到,获得积分10
11秒前
11秒前
11秒前
12秒前
wg发布了新的文献求助10
12秒前
pp发布了新的文献求助10
13秒前
bociic完成签到,获得积分10
14秒前
15秒前
15秒前
一人发布了新的文献求助10
16秒前
LiuShenglan发布了新的文献求助10
18秒前
香蕉觅云的应助被王光宇采纳,获得10
18秒前
秋风的应助被幕后编剧采纳,获得10
19秒前
科目三的应助被风-FBDD采纳,获得10
19秒前
strack完成签到,获得积分10
20秒前
Nole的应助被磕磕采纳,获得30
20秒前
21秒前
彭于晏的应助被dean采纳,获得10
21秒前
夜枭完成签到,获得积分10
21秒前
杨自强完成签到,获得积分10
22秒前
一朵云发布了新的文献求助10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188634
求助须知:如何正确求助?哪些是违规求助? 9576342
关于积分的说明 21847026
捐赠科研通 7786653
什么是DOI,文献DOI怎么找? 3435402
关于科研通互助平台的介绍 2559632
邀请新用户注册赠送积分活动 2482360